Learn how your medicines and genes interact:
Join the EmPaSafe Study!
What the study is about
In the EmPaSafe study, we are looking at patients who take more than one medicine at a time and how we can best improve their health¬care journey to further support their safety and ensure that the multiple medicines they are taking work optimally for them. Our goal is to help patients reduce the number of side effects they experience from taking multiple medications by providing treatment that is specifically tailored to each individual, according to how their genes interact with the medicines. This research is part of the EU-funded SafePolyMed project, which brings together 12 international partners from across Europe.
We appreciate your support and participation! Together we can work towards a more effective use of medications!
Q&A: Taking part in the EmPaSafe Study
Can I participate in the study?
You can participate in the study if you- are 18 years or older,
- take at least four different medicines, and
- have recently started taking one of the following medications:
- a cholesterol-lowering drug (Atorvastatine, Simvastatine)
- an antidepressant (Amitriptyline, Citalopram, Escitalopram, Paroxetine, Sertraline, Venlafaxine)
- painkillers (Tramadol)
What prevents participation in the study?
- pregnancy
- participation in other studies at the same time
How do I benefit from the study?
- You ensure your treatment works better and more safely.
- You learn how medicines and genes can affect each other.
- You help shape treatments tailored to each person’s needs.
What does my participation involve?
- The participation period is 12 weeks.
- Participation does not require additional centre visits.
- Providing either a blood sample (5 mL) or saliva sample to check how your genes influence treatment.
- The use of a web application with diary to track your treatment, well-being, and any side effects (local support available if needed).
- Completing questionnaires at the start, after two weeks, and after 12 weeks (each approx. 30-60 minutes).
Where does the study take place?
- You can participate in four European countries. If you are interested, please contact our local partners.
Do you need further information?
Do not hesitate to contact our local partners or discuss your participation with your physician. Learn more about the study on clinicaltrials.gov.
Get to know the local conditions and requirements on our website or in our special flyers, available in four languages:
